{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:52Z","timestamp":1786991632866,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jchromb.2024.124434","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T11:34:02Z","timestamp":1734780842000},"page":"124434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Green and High Throughput HPTLC Method for Simultaneous Estimation of Celecoxib and Tramadol Hydrochloride in their Newly Approved Analgesic Combination and Spiked Plasma with Dichromic Green and Blue Assessments"],"prefix":"10.1016","volume":"1252","author":[{"given":"Mona M.","family":"Abdel Moneim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.A.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124434_b0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40268-018-0235-y","article-title":"Co-Crystal of Tramadol\u2013Celecoxib in patients with moderate to severe acute post-surgical oral pain: a dose-finding, randomised, double-blind, placebo-and active-controlled, multicentre, phase II trial","volume":"18","author":"L\u00f3pez-Cedr\u00fan","year":"2018","journal-title":"Drugs R d."},{"issue":"Suppl 2","key":"10.1016\/j.jchromb.2024.124434_b0010","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.21037\/jss.2019.09.33","article-title":"Anesthesia and postoperative pain control\u2014multimodal anesthesia protocol","volume":"5","author":"Bhatia","year":"2019","journal-title":"J. Spine Surg."},{"key":"10.1016\/j.jchromb.2024.124434_b0015","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2165\/11208240-000000000-00000","article-title":"Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis","volume":"71","author":"McCormack","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2024.124434_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261239","article-title":"Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis","volume":"16","author":"Cheng","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2024.124434_b0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1389450119666180803121737","article-title":"Celecoxib in cancer therapy and prevention\u2013review","volume":"20","author":"To\u0142oczko-Iwaniuk","year":"2019","journal-title":"Curr. Drug Targets."},{"key":"10.1016\/j.jchromb.2024.124434_b0030","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3390\/curroncol29090482","article-title":"The efficacy and safety of celecoxib in addition to standard cancer therapy: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Ye","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jchromb.2024.124434_b0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2018.12.085","article-title":"An overview of tramadol and its usage in pain management and future perspective","volume":"111","author":"Subedi","year":"2019","journal-title":"Biomed.pharmacother."},{"key":"10.1016\/j.jchromb.2024.124434_b0040","doi-asserted-by":"crossref","unstructured":"S. Nakhaee, c. Hoyte, R.C. Dart, M. Askari, R.J. Lamarine, O. Mehrpour, A review on tramadol toxicity: mechanism of action, clinical presentation, and treatment, Forensic Toxicol. 39 (2021) 293-310. https:\/\/doi.org\/10.1007\/s11419-020-00569-0.","DOI":"10.1007\/s11419-020-00569-0"},{"key":"10.1016\/j.jchromb.2024.124434_b0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40263-019-00623-5","article-title":"Revisiting Tramadol: A Multi-Modal Agent for Pain Management","volume":"33","author":"Barakat","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jchromb.2024.124434_b0050","unstructured":"Kim el Al, United States Patent Application Publication (2018). https:\/\/patentimages.storage.googleapis.com\/3c\/a0\/fe\/bada3acc91506c\/US20180207102A1.pdf last accessed 29 November 2024."},{"key":"10.1016\/j.jchromb.2024.124434_b0055","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/acs.cgd.9b00008","article-title":"Differential solution behavior of the new API\u2013API co-crystal of tramadol\u2013celecoxib (CTC) versus its constituents and their combination","volume":"19","author":"Port","year":"2019","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.jchromb.2024.124434_b0060","doi-asserted-by":"crossref","unstructured":"R. Langford, C. Margarit, A. Morte, J. Cebrecos, M. Sust, E. Ortiz E, et al, Co-crystal of tramadol\u2013celecoxib (CTC) for acute moderate-to-severe pain, Curr. Med. Res. and Opin. 40 (2024) 455-468. DOI:10.1080\/03007995.2023.2276118.","DOI":"10.1080\/03007995.2023.2276118"},{"key":"10.1016\/j.jchromb.2024.124434_b0065","unstructured":"Food and Drug Adminstration, FDA, USA https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2021\/213426Orig1s000ltr.pdf (accessed 6 September 2024)."},{"key":"10.1016\/j.jchromb.2024.124434_b0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejphar.2018.06.022","article-title":"Administration of a co-crystal of tramadol and celecoxib in a 1: 1 molecular ratio produces synergistic antinociceptive effects in a postoperative pain model in rats","volume":"833","author":"Merlos","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.124434_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.124614","article-title":"Spectrophotometric determination of celecoxib and tramadol in the new approved formulated dosage form using principle component regression assistive model","volume":"320","author":"Almalki","year":"2024","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jchromb.2024.124434_b0080","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/jaoacint\/qsac049","article-title":"Quantitative spectrophotometric analysis of celecoxib and tramadol in their multimodal analgesia combination tablets","volume":"105","author":"Abdelazim","year":"2022","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2024.124434_b0085","doi-asserted-by":"crossref","first-page":"11716","DOI":"10.1038\/s41598-023-38702-9","article-title":"Eco-friendly simultaneous multi-spectrophotometric estimation of the newly approved drug combination of celecoxib and tramadol hydrochloride tablets in its dosage form","volume":"13","author":"Ramadan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2024.124434_b0090","doi-asserted-by":"crossref","first-page":"s787","DOI":"10.5530\/ijper.57.3s.89","article-title":"Different Innovative UV-spectroscopic Approaches for Simultaneous Assessment of Celecoxib and Tramadol Hydrochloride in Binary Mixture","volume":"57","author":"Sen","year":"2023","journal-title":"Ind. J. Pharm. Edu. Res."},{"key":"10.1016\/j.jchromb.2024.124434_b0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jaoacint\/qsad133","article-title":"Exciting Advances in Sustainable Spectrophotometric Micro-Quantitation of an Innovative Painkiller \u201cTramadol and Celecoxib\u201d Mixture in the Presence of a Toxic Impurity, Promoting Greenness and Whiteness Studies","volume":"107","author":"Bahgat","year":"2024","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2024.124434_b0100","first-page":"e4774","article-title":"First derivative synchronous spectrofluorimetric method for the simultaneous determination of tramadol and celecoxib in their dosage forms and human plasma","volume":"39","author":"Ramadan","year":"2024","journal-title":"Lumin."},{"key":"10.1016\/j.jchromb.2024.124434_b0105","first-page":"389","article-title":"Green micelle and complex inclusion enhance synchronous spectrofluorimetric quantification of a novel analgesic combination: Tramadol and celecoxib in tablet dosage form and spiked human plasma","volume":"38","author":"Bahgat","year":"2023","journal-title":"Lumin."},{"key":"10.1016\/j.jchromb.2024.124434_b0110","first-page":"g307","article-title":"Stability indicating RP-HPLC method development and validation for simultaneous estimation of celecoxib and tramadol HCL in synthetic mixture","volume":"11","author":"Kunjan","year":"2023","journal-title":"IJCRT"},{"key":"10.1016\/j.jchromb.2024.124434_b0115","doi-asserted-by":"crossref","unstructured":"H-AI. Mandour, T.S. Belal, A.A. Ramadan, F.M. Sharabi, M.A. Shamseddeen, Qualitative and quantitative analysis of some tramadol registered and illegitimate dosage forms in Egypt, J. Adv. Pharm. Sci. 1 (2024) 11-21. DOI:10.21608\/japs.2024.255337.1011.","DOI":"10.21608\/japs.2024.255337.1011"},{"key":"10.1016\/j.jchromb.2024.124434_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.saa.2014.01.036","article-title":"Simultaneous spectrophotometric determination of celecoxib and diacerein in bulk and capsule by absorption correction method and chemometric methods","volume":"125","author":"Patel","year":"2014","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jchromb.2024.124434_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118533","article-title":"An enhanced first derivative synchronous spectrofluorimetric method for determination of the newly co-formulated drugs, amlodipine and celecoxib in pharmaceutical preparation and human plasma","volume":"240","author":"Attala","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jchromb.2024.124434_b0130","doi-asserted-by":"crossref","unstructured":"A.S. Radwan, M.A. El Hamd, M. El-Maghrabey, F.R. Mansour, W.A. Mahdi, S. Alshehri S, et al, A highly sensitive first derivative synchronous spectrofluorimetric approach for the simultaneous analysis of the anti-breast cancer co-administered drugs, letrozole and tramadol in dosage forms and human plasma at nanogram levels, Spectrochim. Acta A Mol. Biomol. Spectrosc. (2024) 124532. DOI:10.1016\/j.saa.2024.124532.","DOI":"10.1016\/j.saa.2024.124532"},{"key":"10.1016\/j.jchromb.2024.124434_b0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1134\/S106193481503020X","article-title":"TLC determination of piroxicam, tenoxicam, celecoxib and rofecoxib in biological material","volume":"70","author":"Starek","year":"2015","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124434_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116109","article-title":"Green innovation in analytical chemistry: A sustainable densitometric HPTLC approach for the distinctive separation and quantification of structurally related abused drugs-tramadol, tapentadol, and venlafaxine-in seized pharmaceutical dosage forms","volume":"243","author":"Heneedak","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124434_b0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/bmc.1596","article-title":"Celecoxib determination in different layers of skin by a newly developed and validated HPLC\u2010UV method","volume":"25","author":"Pra\u00e7a","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124434_b0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1556\/1326.2021.00901","article-title":"HPLC-fluorescence detection for assay of tramadol binary mixtures with ibuprofen or chlorzoxazone in tablets and plasma: Analytical Eco-Scale and GAPI tools for green assessment","volume":"34","author":"Hamdy","year":"2021","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jchromb.2024.124434_b0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchromb.2012.06.016","article-title":"Development of simple and rapid LC\u2013MS\/MS method for determination of celecoxib in human plasma and its application to bioequivalence study","volume":"902","author":"Park","year":"2012","journal-title":"J. Chromatogr. b."},{"key":"10.1016\/j.jchromb.2024.124434_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114171","volume":"203","author":"Al-Qurain","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124434_b0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2116\/analsci.29.855","article-title":"Electrochemical determination of celecoxib on a graphene based carbon ionic liquid electrode modified with gold nanoparticles and its application to pharmaceutical analysis","volume":"29","author":"Arkan","year":"2013","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jchromb.2024.124434_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.104942","article-title":"A rapid and selective electrochemical sensor based on electrospun carbon nanofibers for tramadol detection","volume":"157","author":"Jahromi","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2024.124434_b0175","series-title":"Validation of a analytical procedures: text and methodology Q2(R1)","author":"Guidelines","year":"2022"},{"key":"10.1016\/j.jchromb.2024.124434_b0180","unstructured":"FDA, Bioanalytical Method Validation Guidance for Industry (2018). https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"key":"10.1016\/j.jchromb.2024.124434_b0185","unstructured":"Celecoxib, Drug Bank, https:\/\/go.drugbank.com\/drugs\/DB00482. (Accessed 6 September 2024)."},{"key":"10.1016\/j.jchromb.2024.124434_b0190","unstructured":"Tramadol, Drug Bank, https:\/\/go.drugbank.com\/drugs\/DB00193. (Accessed 6 September 2024)."},{"key":"10.1016\/j.jchromb.2024.124434_b0195","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness Metric Approach and Software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124434_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116553","article-title":"AGREEprep - Analytical Greenness Metric for Sample Preparation","volume":"149","author":"Wojnowski","year":"2022","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124434_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2024.100126","article-title":"A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness","volume":"10","author":"Mansour","year":"2024","journal-title":"Green Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124434_b0210","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T21:23:23Z","timestamp":1738445003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224004434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"alternative-id":["S1570023224004434"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124434","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Green and High Throughput HPTLC Method for Simultaneous Estimation of Celecoxib and Tramadol Hydrochloride in their Newly Approved Analgesic Combination and Spiked Plasma with Dichromic Green and Blue Assessments","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124434"}}